diluting semaglutide FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable products Semaglutide and Alcohol: Safety Tips

Lotte Bjerre Knudsen, chief scientific advisor in research and early development at Novo Nordisk, discusses the past and future of GLP-1s and related anti-obesity drugs.

A skipped semaglutide dose happens to many patients

Thinking about GLP-1s like Ozempic for cycling weight loss

Objective This systematic review aims to synthesise published evidence on respiratory adverse events temporally associated with GLP-1 RA therapy in adults, characterise their patterns and severity, appraise the risk of bias using validated design-appropriate tools, describe proposed pathophysiological mechanisms, and grade the certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework

The medication has a triple action on GLP-1,